Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2005
11/09/2005EP1593312A1 Antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine
11/09/2005EP1592427A1 Multivitamin regimen for renal patients
11/09/2005EP1592417A1 Combination of antidiabetic drugs
11/09/2005EP1592312A2 Preparation and food product comprising an active phytase
11/09/2005EP1549334A4 A pharmaceutical composition comprising a retro-iverso isomer pettide
11/09/2005EP1480983B1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
11/09/2005EP1480981B1 1-(alkyl), 1-(heteroaryl)alkyl and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
11/09/2005EP1409531B1 Heterocarpine, a human ghrh-binding protein
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1368025B1 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
11/09/2005EP1278729B1 Benzosuberonylpiperidine compounds as analgesics
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1220932B1 Human carboxypeptidases and polynucleotides encoding the same
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1189605B1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP1043982B1 Lipase inhibiting polymers
11/09/2005EP1019089B1 Long-acting drugs and pharmaceutical compositions comprising them
11/09/2005EP0751992B1 Vascular endothelial growth factor 2
11/09/2005CN1694960A Use of saccharomyces cerevisiae ERG4 mutants for expressing mammalian glucose transporters
11/09/2005CN1694901A Kdr peptides and vaccines comprising the same
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694881A New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1694719A Casein derived peptides and uses thereof in therapy
11/09/2005CN1694707A Pde-v inhibitor and medicine composite with active agent
11/09/2005CN1694695A Novel nutraceutical compositions comprising epigallocatechin gallate
11/09/2005CN1692906A Composite for treating hyperlipidemia
11/09/2005CN1226294C Fused heteroaromatic glucokinase activators
11/09/2005CN1226290C Ligands of nuclear receptor
11/09/2005CN1226039C Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962969 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/08/2005US6962939 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005US6962931 Oral bioavailability of a CETP inhibitor
11/08/2005US6962915 Antiinflammatory agents
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103288A1 Screening method
11/03/2005WO2005103046A1 Selenophen derivatives and the use of preventing and/or treating the diseases relating to protein aging thereof
11/03/2005WO2005103017A1 Method for increasing specific surface area of slightly soluble drug
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102981A1 Novel compounds and medicinal use thereof
11/03/2005WO2005102381A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth
11/03/2005WO2005102377A1 Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusion
11/03/2005WO2005102376A1 Preventive/remedy for diabetic nephropathy
11/03/2005WO2005102357A1 Compositions comprising one or more policosanols and/or policosanoic acids combined with sterol and/or steroid based ascorbic acid derivatives, and uses thereof
11/03/2005WO2005102321A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
11/03/2005WO2005102301A2 Hydroxymethylbutyrate compositions and uses thereof
11/03/2005WO2005102072A1 Process for producing whitish banaba extract, whitish banaba extract and food or drink containing whitish banaba extract
11/03/2005WO2005067952A8 Formulation for treating obesity and associated metabolic syndrome
11/03/2005WO2002004440A9 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
11/03/2005US20050245765 Partially hydrolyzing methyl formates with water; forming a formic acid/water stream; reacting the methyl formate stream with a base in the presence of water; distilling off methanol; and combining the formic acid and water stream with the formate and water stream
11/03/2005US20050245750 Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
11/03/2005US20050245743 depression and/or anxiety, obesity, urinary disorder; 5-(2-Methoxyphenyl)-N-[3-(4-Piperidinyl)Phenyl]Pentanamide
11/03/2005US20050245736 Low molecular weight oversulfated polysaccharide
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245584 Peroxisome proliferator activated receptor agonists
11/03/2005US20050245575 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
11/03/2005US20050245571 Amine derivative
11/03/2005US20050245570 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
11/03/2005US20050245567 Novel quinuclidine derivatives and their use
11/03/2005US20050245552 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
11/03/2005US20050245545 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
11/03/2005US20050245538 Dipeptidyl peptidase inhibitor; antidiabetic agents; obesity; viricides; anticancer agents; oral diseases; autoimmune disease
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245527 Nitrogen containing heterocyclic compounds and medicines containing the same
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245514 Novel physiologically active substances
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245507 7-Phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
11/03/2005US20050245441 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244829 Method of screening insulin resistance inproving drug
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244426 Administering yeast comprising Issatchenkia, Kluyveromyces, Hanseniaspora, Saccharomyces, Hyphopichia, Candida, Torulaspora, Pichia, and/or Zygosaccharomyces; anticholesterol and anticarcinogenic agents; hypertriglyceridemia, hyperlipemia, atherosclerosis, arteriosclerosis; cardiovascular disorders
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005US20050244382 Compositions including ammonia oxidizing bacteria and methods of using same
11/03/2005DE102004008017A1 Increasing nutrient bioavailability comprises administering a dietary supplement together with a galactomannan or glucomannan
11/03/2005CA2807787A1 Hmb compositions and uses thereof
11/03/2005CA2798552A1 Poly(lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
11/03/2005CA2563952A1 Use of the pregnane glycosides in the treatment/management of obesity, obesity-related and other disorders
11/03/2005CA2563192A1 Tri(cyclo) substituted amide compounds
11/03/2005CA2560042A1 Hmb compositions and uses thereof
11/03/2005CA2559688A1 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds
1 ... 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 ... 1298